Physician profile
Bryan Thiel
NPI 1356845556
$1,258.89
in general payments reported to CMS, 2019-2025
12 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $289 · 2024: $447 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.80 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $530.57 | 2022-2025 | Cequa |
| Bausch & Lomb Americas INC. | $313.68 | 2023-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Alcon Vision LLC | $91.02 | 2023-2024 | Clareon |
| Dompe US, INC. | $61.42 | 2024-2025 | Oxervate |
| Glaukos Corporation | $60.87 | 2025 | Idosetr |
| Abbvie INC. | $49.04 | 2023-2025 | Durysta |
| Amgen INC. | $39.85 | 2024 | Tepezza |
| Oyster Point Pharma, INC. | $28.53 | 2024 | Tyrvaya |
| Biotissue Holdings INC. | $24.99 | 2025 | |
| Harrow Eye, LLC | $22.15 | 2024 | Vevye |
| New World Medical,INC. | $21.95 | 2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Johnson & Johnson Surgical Vision, INC. | $14.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Thiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.